Using Mounjaro for Weight Loss: What the Evidence Actually Shows

Step 1: Understanding what Mounjaro actually does in the body

Most weight-loss medicines work on a single pathway. Mounjaro works on two. It activates both the GIP and GLP-1 receptors, which are involved in how your gut signals fullness to your brain, how quickly food moves through your stomach, and how your body handles blood sugar. The result is a meaningful reduction in appetite that most people notice within the first few weeks of treatment. Slowed gastric emptying means meals feel more satisfying on smaller portions, and many people find the pull towards habitual or emotional eating becomes quieter over time.

This dual mechanism is what distinguishes tirzepatide from semaglutide (Wegovy), which targets the GLP-1 pathway only. The SURMOUNT-5 trial, published in the New England Journal of Medicine in 2025, compared the two head-to-head over 72 weeks and found tirzepatide produced greater average weight reduction. That said, individual responses vary, and which medicine suits a given person is a clinical decision. You can read more about how the two treatments compare on our treatment overview page.

It is worth being clear that Mounjaro is not a standalone solution. The licence specifies use alongside a reduced-calorie diet and increased physical activity. The medicine lowers the barrier; the lifestyle work still matters, and our prescribers discuss both at consultation.

Step 2: Checking whether you meet the eligibility criteria

The licensed eligibility criteria for Mounjaro in the UK are set out in the medicine's SmPC and summarised by the NHS tirzepatide medicines page: adults with a BMI of 30 or above, or 27 or above if at least one weight-related condition is present. Conditions that count include type 2 diabetes, high blood pressure, high cholesterol, prediabetes, obstructive sleep apnoea, and osteoarthritis, among others. For some ethnic backgrounds, the relevant BMI thresholds are 2.5 kg/m² lower under UK guidance, in line with evidence that health risks associated with excess weight occur at lower BMIs in these groups.

BMI alone does not guarantee approval. A prescriber reviews your full medical picture, including current medicines, any history of pancreatitis, thyroid conditions, and other contraindications listed in the SmPC. Mounjaro is not licensed for use in pregnancy, breastfeeding, or by anyone trying to conceive, and it is not licensed for under-18s. If you are on an oral contraceptive, there is specific guidance on adding a barrier method during the first four weeks of treatment and after each dose increase, because tirzepatide can reduce how much of the pill is absorbed. Our clinical team covers this at consultation.

If you want to understand the private eligibility route in more detail before booking, the guide on how to get Mounjaro for weight loss explains the process step by step.

Step 3: Starting treatment and knowing what to expect

The first pen contains the 2.5mg dose. Its job is to settle your system, not to produce rapid weight loss, and the titration schedule exists precisely so that the gastrointestinal side effects that can accompany GLP-1 and dual-agonist medicines are manageable from the start. Nausea is the most commonly reported effect, alongside looser stools, constipation, or indigestion. For most people these are mild and settle as the body adapts, particularly if meals are kept smaller and lower in fat during the early weeks. Our practical tips for people starting Mounjaro go into the dietary detail that can make a real difference in those first weeks.

Dose increases typically happen every four weeks, guided by your prescriber based on how well the current dose is tolerated and how treatment is progressing. Decisions about titration timing are always made by the prescriber, not by a fixed automatic schedule. The maintenance doses where the majority of weight-loss effect is seen are the higher ones, so the early period is genuinely about building towards treatment, not a disappointment if the scales move slowly.

If you're curious about what results typically look like across different people, our Mounjaro weight loss page covers the evidence and what realistic outcomes tend to involve. The SURMOUNT-1 data showed continued reduction across the full 72-week trial period, with the curve still descending at the final timepoint for many participants. Realistic expectation-setting matters: some people lose more, some less, and results depend on adherence, lifestyle changes, and individual physiology. NICE's appraisal of tirzepatide (TA1026) recommends reviewing whether treatment is achieving sufficient benefit at six months, which is also how our prescribers approach ongoing care.

The private route and what it includes at nume

On the NHS, tirzepatide is available through a phased rollout with strict eligibility criteria that currently require a high BMI and multiple qualifying conditions. Many people who would benefit clinically don't yet meet those thresholds or face a long wait. Private treatment through a regulated online pharmacy is the practical alternative for them.

At nume, the consultation is free, reviewed the same day by a GPhC-registered Independent Prescriber (a real clinician, not automated software), and includes identity and weight verification by video. If treatment is approved and you order before midday Monday to Friday, your medicine is dispatched the same day and delivered free the next working day by DPD, in plain unbranded packaging. There are no subscriptions, no auto-renewals, and every repeat order is reviewed clinically before it ships. We also have dedicated guidance for those who want to explore Mounjaro weight loss for men, including how results and tolerability can differ. For context on what private treatment typically costs and what a legitimate price includes, our Mounjaro pricing page covers that honestly.

If you'd like to find out whether you're a suitable candidate, the right next step is to check your eligibility with a free consultation. Our prescribers are there to give you a straight answer, one way or the other. If you are taking any supplements alongside treatment, it is also worth reading about how ashwagandha and Mounjaro interact, as our clinical team can advise on what is appropriate to continue.